Pharmsville Co., Ltd. (KOSDAQ:318010)
South Korea · Delayed Price · Currency is KRW 3,760.00
+5.00 (0.13%)
At close: Apr 17, 2026
Pharmsville Revenue
In the year 2025, Pharmsville had annual revenue of 12.73B KRW, down -23.90%. Pharmsville had revenue of 2.96B in the quarter ending December 31, 2025, a decrease of -17.56%.
Revenue
12.73B
Revenue Growth
-23.90%
P/S Ratio
2.28
Revenue / Employee
454.58M
Employees
28
Market Cap
29.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.73B | -4.00B | -23.90% |
| Dec 31, 2024 | 16.72B | -4.67B | -21.83% |
| Dec 31, 2023 | 21.39B | -4.72B | -18.07% |
| Dec 31, 2022 | 26.11B | -12.91B | -33.09% |
| Dec 31, 2021 | 39.03B | -381.05M | -0.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hurum | 99.01B |
| GeneBioTech Co. ,Ltd | 90.79B |
| Korean Drug | 62.51B |
| ChoA Pharmaceutical Co., LTD. | 59.31B |
| WooGene B&G | 54.76B |
| Seoul Pharma | 52.15B |
| Kwangdong Healthbio | 38.10B |
| Union Korea Pharm | 36.38B |